SomaLogic Inc. is beginning a merger with a special purpose acquisition company that would add up to $651 million in new funding to the company’s books, and make it Colorado’s latest unicorn.
Casdin goes all-in on the SPAC game with $385M offering
Two of biotech’s biggest trends — the rise of SPACs and the Scrooge McDuck piles of cash suddenly available to a life sciences company on New York trading floors — converged late Wednesday in one of the largest life sciences SPAC offerings yet: $385 million.